Dose: 42.857 mg/kg
Single Dose: 43 (42.857)
Frequency: As recommended.
Route: PO
Instructions: Once,as required

. It is of Synthetic origin and belongs to Iodinated Organic Compounds. It belongs to Radiopaque Agents pharmacological group on the basis of mechanism of action and also classified in Diagnostic Aids pharmacological group.The Molecular Weight of Iopanoic Acid is 571.00. Its pKa is 4.8.

Iopanoic Acid is contraindicated in conditions like Cardiovascular disease,Malabsorption.

The severe or irreversible adverse effects of Iopanoic Acid, which give rise to further complications include Thrombocytopenia, Renal impairment, Thyrotoxicosis, Urate nephropathy, Hepatic impairment.Iopanoic Acid produces potentially life-threatening effects which include Anaphylactoid reactions, Coronary insufficiency, Cardiovascular collapse. which are responsible for the discontinuation of Iopanoic Acid therapy.The signs and symptoms that are produced after the acute overdosage of Iopanoic Acid include Diarrhea, Nausea & vomiting.The symptomatic adverse reactions produced by Iopanoic Acid are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Diarrhea, Abdominal pain, Rashes, Urticaria, Pruritus, Dysuria, Cramps, Nausea and vomiting, Heart burn, Hypersensitivity reactions, Sore throat, dizziness.

Iopanoic Acid is primarily indicated in conditions like Cholecystography, Epilepsy (monotherapy), Radiological contrast agent, Vestibular disorders, and can also be given in adjunctive therapy as an alternative drug of choice in Hyperthyroidism.

No data regarding the interactions of Iopanoic Acid was found.

Thyroid Function Test False +ver result of Sulphosalicylic acid test Pisano Test Serum Urate Measurement Increases Sulphobromophthaline retention Increases Serum Bilirubin

Drug should not be given to Paediatrics, Pregnant Mothers, patients suffering from Kidney dysfunction, patients suffering from Liver Malfunction, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Tab Store at room temperature. Protect from Sunlight.

Avoid use of iopanoic acid in patients with severe renal (kidney) or hepatic (liver) disease. Dose higher than 3gm should not be given to patients with renal impairment. Avoid use in presence of acute gastro-intestinal disease, as it may impair the absorption. It should be used with caution in patients with history of hypersensitivity to iodine, or other contrast media, hyperthyroidism, hyperuricaemia.